# FDA Inspection 1049436 - Ajanta Pharma USA Inc - April 04, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-usa-inc/2bdaced5-f9b8-4fba-a2aa-5afbc881b127/
Source feed: FDA_Inspections

> FDA Inspection 1049436 for Ajanta Pharma USA Inc on April 04, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049436
- Company Name: Ajanta Pharma USA Inc
- Inspection Date: 2018-04-04
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276284 - 2025-07-22](https://www.globalkeysolutions.net/api/records/fda_inspections/ajanta-pharma-usa-inc/1d8acbb1-7ee0-4892-af23-e92b91353591/)
- [FDA Inspection 1276284 - 2025-07-22](https://www.globalkeysolutions.net/api/records/fda_inspections/ajanta-pharma-usa-inc/659b0944-41d5-43b5-a2ed-eb7d4abb5387/)
- [FDA Inspection 965140 - 2016-03-17](https://www.globalkeysolutions.net/api/records/fda_inspections/ajanta-pharma-usa-inc/923413a9-339f-459b-b453-59bc8a5fed91/)

Company: https://www.globalkeysolutions.net/companies/ajanta-pharma-usa-inc/fb94ebd3-ce80-4426-8f91-9f82716e5ea6

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c